US equities |
MU $914.13 ▲+0.00% NVDA $221.30 ▲+0.00% SNDK $1,403.34 ▲+0.00% SKHY $147.55 ▲+0.00% SPCX $152.16 ▲+0.00% INTC $98.00 ▼-0.12% TSM $430.00 ▲+0.00% AMD $570.82 ▲+0.00%
FinancialContent

Biofrontera Inc. - Warrants (NQ:BFRIW)

0.0056 UNCHANGED
Last Price Updated: 3:53 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biofrontera Inc. - Warrants

News headline image
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan
From Biofrontera Inc.
Via GlobeNewswire
News headline image
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
From Biofrontera Inc.
Via GlobeNewswire